Market Overview:
The global genomics market exhibited strong growth during 2015-2020. Looking forward, IMARC Group expects the market to grow at a CAGR of around 16% during 2021-2026. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.
Genomics refers to the study of the structure, function and inheritance of the genetic material present in the deoxyribonucleic acid (DNA) of an organism. It addresses the intrarelationship of all genes to identify their combined influence on the overall growth and development. It involves various consumables, systems, software and services for diagnostics, drug discovery, development of precision medicine and agricultural research. Some of the technologies used for genomics include microarray, sequencing, polymerase chain reaction (PCR), nucleic acid extraction and purification and single-cell genomics analysis. These techniques are highly effective in solving complex genetic problems.
The increasing adoption of non-invasive cancer screening-based research, along with the growing demand for personalized medicines, is one of the key factors driving the growth of the market. Furthermore, the rising incidences of chronic diseases is also providing a boost to the market growth. Clinical workflows are widely being integrated with genomic data for the production of targeted and personalized medicines and for studying the growth of newborn genetic screening programs and military genomics. This, along with the growing demand for genetically modified plants and organisms in the agriculture sector, is creating a positive impact on the market growth. Various technological advancements, including the development of genomics-based apps and tests, are acting as another major growth-inducing factor. Other factors, such as extensive research and development (R&D) activities in the field of bioinformatics and the increasing demand for next-generation sequencing services, are projected to drive the market further.
Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global genomics market, along with forecasts at the global, regional and country level from 2021-2026. Our report has categorized the market based on component, application, technology and end-user.
Breakup by Component:
- Products
- Instruments and Software
- Consumables and Reagents
- Services
- Core Genomics Services
- NGS-Based Services
- Biomarker Translation Services
- Computational Services
- Others
Breakup by Application:
- Functional Genomics
- Epigenomics
- Biomarkers Discovery
- Pathway Analysis
- Others
Breakup by Technology:
- Sequencing
- Microarray
- Polymerase Chain Reaction
- Nucleic Acid Extraction and Purification
- Others
Breakup by End-User:
- Research Centers
- Hospitals and Clinics
- Pharmaceutical and Biotechnology Companies
- Others
Breakup by Region:
- North America
- Asia Pacific
- China
- Japan
- India
- South Korea
- Australia
- Indonesia
- Others
- Europe
- Germany
- France
- United Kingdom
- Italy
- Spain
- Russia
- Others
- Latin America
- Middle East and Africa
Competitive Landscape:
The report has also analysed the competitive landscape of the market with some of the key players being 23andMe Inc., Agilent Technologies Inc., Bayer Aktiengesellschaft, BGI Genomics Co. Ltd., Bio-RAD Laboratories Inc., Danaher Corporation, Illumina Inc., Oxford Nanopore Technologies, PerkinElmer Inc., Myriad Genetics Inc., Roche Holding AG, Thermo Fisher Scientific Inc., etc.
Report Coverage:
| Report Features |
Details |
|---|
| Base Year of the Analysis |
2020 |
| Historical Period |
2015-2020 |
| Forecast Period |
2021-2026 |
| Units |
US$ Billion |
| Segment Coverage |
Component, Application, Technology, End-User, Region |
| Region Covered |
Asia Pacific, Europe, North America, Latin America, Middle East and Africa |
| Countries Covered |
United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico |
| Companies Covered |
23andMe Inc., Agilent Technologies Inc., Bayer Aktiengesellschaft, BGI Genomics Co. Ltd., Bio-RAD Laboratories Inc., Danaher Corporation, Illumina Inc., Oxford Nanopore Technologies, PerkinElmer Inc., Myriad Genetics Inc., Roche Holding AG and Thermo Fisher Scientific Inc. |
| Customization Scope |
10% Free Customization |
| Report Price and Purchase Option |
Single User License: US$ 2299
Five User License: US$ 3399
Corporate License: US$ 4499 |
| Post-Sale Analyst Support |
10-12 Weeks |
| Delivery Format |
PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request) |
Key Questions Answered in This Report:
- How has the global genomics market performed so far and how will it perform in the coming years?
- What are the key regional markets?
- What has been the impact of COVID-19 on the global genomics market?
- What is the breakup of the market based on the component?
- What is the breakup of the market based on the application?
- What is the breakup of the market based on the technology?
- What is the breakup of the market based on the end-user?
- What are the various stages in the value chain of the industry?
- What are the key driving factors and challenges in the industry?
- What is the structure of the global genomics market and who are the key players?
- What is the degree of competition in the industry?
1 Preface
2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
4.1 Overview
4.2 Key Industry Trends
5 Global Genomics Market
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast
6 Market Breakup by Component
6.1 Products
6.1.1 Market Trends
6.1.2 Major Types
6.1.2.1 Instruments and Software
6.1.2.2 Consumables and Reagents
6.1.3 Market Forecast
6.2 Services
6.2.1 Market Trends
6.2.2 Major Types
6.2.2.1 Core Genomics Services
6.2.2.2 NGS-Based Services
6.2.2.3 Biomarker Translation Services
6.2.2.4 Computational Services
6.2.2.5 Others
6.2.3 Market Forecast
7 Market Breakup by Application
7.1 Functional Genomics
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Epigenomics
7.2.1 Market Trends
7.2.2 Market Forecast
7.3 Biomarkers Discovery
7.3.1 Market Trends
7.3.2 Market Forecast
7.4 Pathway Analysis
7.4.1 Market Trends
7.4.2 Market Forecast
7.5 Others
7.5.1 Market Trends
7.5.2 Market Forecast
8 Market Breakup by Technology
8.1 Sequencing
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Microarray
8.2.1 Market Trends
8.2.2 Market Forecast
8.3 Polymerase Chain Reaction
8.3.1 Market Trends
8.3.2 Market Forecast
8.4 Nucleic Acid Extraction and Purification
8.4.1 Market Trends
8.4.2 Market Forecast
8.5 Others
8.5.1 Market Trends
8.5.2 Market Forecast
9 Market Breakup by End-User
9.1 Research Centers
9.1.1 Market Trends
9.1.2 Market Forecast
9.2 Hospitals and Clinics
9.2.1 Market Trends
9.2.2 Market Forecast
9.3 Pharmaceutical and Biotechnology Companies
9.3.1 Market Trends
9.3.2 Market Forecast
9.4 Others
9.4.1 Market Trends
9.4.2 Market Forecast
10 Market Breakup by Region
10.1 North America
10.1.1 United States
10.1.1.1 Market Trends
10.1.1.2 Market Forecast
10.1.2 Canada
10.1.2.1 Market Trends
10.1.2.2 Market Forecast
10.2 Asia Pacific
10.2.1 China
10.2.1.1 Market Trends
10.2.1.2 Market Forecast
10.2.2 Japan
10.2.2.1 Market Trends
10.2.2.2 Market Forecast
10.2.3 India
10.2.3.1 Market Trends
10.2.3.2 Market Forecast
10.2.4 South Korea
10.2.4.1 Market Trends
10.2.4.2 Market Forecast
10.2.5 Australia
10.2.5.1 Market Trends
10.2.5.2 Market Forecast
10.2.6 Indonesia
10.2.6.1 Market Trends
10.2.6.2 Market Forecast
10.2.7 Others
10.2.7.1 Market Trends
10.2.7.2 Market Forecast
10.3 Europe
10.3.1 Germany
10.3.1.1 Market Trends
10.3.1.2 Market Forecast
10.3.2 France
10.3.2.1 Market Trends
10.3.2.2 Market Forecast
10.3.3 United Kingdom
10.3.3.1 Market Trends
10.3.3.2 Market Forecast
10.3.4 Italy
10.3.4.1 Market Trends
10.3.4.2 Market Forecast
10.3.5 Spain
10.3.5.1 Market Trends
10.3.5.2 Market Forecast
10.3.6 Russia
10.3.6.1 Market Trends
10.3.6.2 Market Forecast
10.3.7 Others
10.3.7.1 Market Trends
10.3.7.2 Market Forecast
10.4 Latin America
10.4.1 Brazil
10.4.1.1 Market Trends
10.4.1.2 Market Forecast
10.4.2 Mexico
10.4.2.1 Market Trends
10.4.2.2 Market Forecast
10.4.3 Others
10.4.3.1 Market Trends
10.4.3.2 Market Forecast
10.5 Middle East and Africa
10.5.1 Market Trends
10.5.2 Market Breakup by Country
10.5.3 Market Forecast
11 SWOT Analysis
11.1 Overview
11.2 Strengths
11.3 Weaknesses
11.4 Opportunities
11.5 Threats
12 Value Chain Analysis
13 Porters Five Forces Analysis
13.1 Overview
13.2 Bargaining Power of Buyers
13.3 Bargaining Power of Suppliers
13.4 Degree of Competition
13.5 Threat of New Entrants
13.6 Threat of Substitutes
14 Price Indicators
15 Competitive Landscape
15.1 Market Structure
15.2 Key Players
15.3 Profiles of Key Players
15.3.1 23andMe, Inc.
15.3.1.1 Company Overview
15.3.1.2 Product Portfolio
15.3.2 Agilent Technologies, Inc.
15.3.2.1 Company Overview
15.3.2.2 Product Portfolio
15.3.2.3 Financials
15.3.2.4 SWOT Analysis
15.3.3 Bayer Aktiengesellschaft
15.3.3.1 Company Overview
15.3.3.2 Product Portfolio
15.3.3.3 Financials
15.3.3.4 SWOT Analysis
15.3.4 BGI Genomics Co. Ltd.
15.3.4.1 Company Overview
15.3.4.2 Product Portfolio
15.3.4.3 Financials
15.3.5 Bio-RAD Laboratories Inc.
15.3.5.1 Company Overview
15.3.5.2 Product Portfolio
15.3.5.3 Financials
15.3.5.4 SWOT Analysis
15.3.6 Danaher Corporation
15.3.6.1 Company Overview
15.3.6.2 Product Portfolio
15.3.6.3 Financials
15.3.6.4 SWOT Analysis
15.3.7 Illumina Inc.
15.3.7.1 Company Overview
15.3.7.2 Product Portfolio
15.3.7.3 Financials
15.3.7.4 SWOT Analysis
15.3.8 Oxford Nanopore Technologies
15.3.8.1 Company Overview
15.3.8.2 Product Portfolio
15.3.8.3 Financials
15.3.8.4 SWOT Analysis
15.3.9 PerkinElmer Inc.
15.3.9.1 Company Overview
15.3.9.2 Product Portfolio
15.3.10 Myriad Genetics Inc.
15.3.10.1 Company Overview
15.3.10.2 Product Portfolio
15.3.11 Roche Holding AG
15.3.11.1 Company Overview
15.3.11.2 Product Portfolio
15.3.11.3 Financials
15.3.12 Thermo Fisher Scientific Inc.
15.3.12.1 Company Overview
15.3.12.2 Product Portfolio
15.3.12.3 Financials
15.3.12.4 SWOT Analysis
List of Figures
Figure 1: Global: Genomics Market: Major Drivers and Challenges
Figure 2: Global: Genomics Market: Sales Value (in Billion US$), 2015-2020
Figure 3: Global: Genomics Market: Breakup by Component (in %), 2020
Figure 4: Global: Genomics Market: Breakup by Application (in %), 2020
Figure 5: Global: Genomics Market: Breakup by Technology (in %), 2020
Figure 6: Global: Genomics Market: Breakup by End-User (in %), 2020
Figure 7: Global: Genomics Market: Breakup by Region (in %), 2020
Figure 8: Global: Genomics Market Forecast: Sales Value (in Billion US$), 2021-2026
Figure 9: Global: Genomics (Products) Market: Sales Value (in Million US$), 2015 & 2020
Figure 10: Global: Genomics (Products) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 11: Global: Genomics (Services) Market: Sales Value (in Million US$), 2015 & 2020
Figure 12: Global: Genomics (Services) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 13: Global: Genomics (Functional Genomics) Market: Sales Value (in Million US$), 2015 & 2020
Figure 14: Global: Genomics (Functional Genomics) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 15: Global: Genomics (Epigenomics) Market: Sales Value (in Million US$), 2015 & 2020
Figure 16: Global: Genomics (Epigenomics) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 17: Global: Genomics (Biomarkers Discovery) Market: Sales Value (in Million US$), 2015 & 2020
Figure 18: Global: Genomics (Biomarkers Discovery) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 19: Global: Genomics (Pathway Analysis) Market: Sales Value (in Million US$), 2015 & 2020
Figure 20: Global: Genomics (Pathway Analysis) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 21: Global: Genomics (Other Applications) Market: Sales Value (in Million US$), 2015 & 2020
Figure 22: Global: Genomics (Other Applications) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 23: Global: Genomics (Sequencing) Market: Sales Value (in Million US$), 2015 & 2020
Figure 24: Global: Genomics (Sequencing) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 25: Global: Genomics (Microarray) Market: Sales Value (in Million US$), 2015 & 2020
Figure 26: Global: Genomics (Microarray) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 27: Global: Genomics (Polymerase Chain Reaction) Market: Sales Value (in Million US$), 2015 & 2020
Figure 28: Global: Genomics (Polymerase Chain Reaction) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 29: Global: Genomics (Nucleic Acid Extraction and Purification) Market: Sales Value (in Million US$), 2015 & 2020
Figure 30: Global: Genomics (Nucleic Acid Extraction and Purification) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 31: Global: Genomics (Other Technologies) Market: Sales Value (in Million US$), 2015 & 2020
Figure 32: Global: Genomics (Other Technologies) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 33: Global: Genomics (Research Centers) Market: Sales Value (in Million US$), 2015 & 2020
Figure 34: Global: Genomics (Research Centers) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 35: Global: Genomics (Hospitals and Clinics) Market: Sales Value (in Million US$), 2015 & 2020
Figure 36: Global: Genomics (Hospitals and Clinics) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 37: Global: Genomics (Pharmaceutical and Biotechnology Companies) Market: Sales Value (in Million US$), 2015 & 2020
Figure 38: Global: Genomics (Pharmaceutical and Biotechnology Companies) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 39: Global: Genomics (Other End-Users) Market: Sales Value (in Million US$), 2015 & 2020
Figure 40: Global: Genomics (Other End-Users) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 41: North America: Genomics Market: Sales Value (in Million US$), 2015 & 2020
Figure 42: North America: Genomics Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 43: United States: Genomics Market: Sales Value (in Million US$), 2015 & 2020
Figure 44: United States: Genomics Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 45: Canada: Genomics Market: Sales Value (in Million US$), 2015 & 2020
Figure 46: Canada: Genomics Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 47: Asia Pacific: Genomics Market: Sales Value (in Million US$), 2015 & 2020
Figure 48: Asia Pacific: Genomics Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 49: China: Genomics Market: Sales Value (in Million US$), 2015 & 2020
Figure 50: China: Genomics Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 51: Japan: Genomics Market: Sales Value (in Million US$), 2015 & 2020
Figure 52: Japan: Genomics Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 53: India: Genomics Market: Sales Value (in Million US$), 2015 & 2020
Figure 54: India: Genomics Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 55: South Korea: Genomics Market: Sales Value (in Million US$), 2015 & 2020
Figure 56: South Korea: Genomics Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 57: Australia: Genomics Market: Sales Value (in Million US$), 2015 & 2020
Figure 58: Australia: Genomics Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 59: Indonesia: Genomics Market: Sales Value (in Million US$), 2015 & 2020
Figure 60: Indonesia: Genomics Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 61: Others: Genomics Market: Sales Value (in Million US$), 2015 & 2020
Figure 62: Others: Genomics Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 63: Europe: Genomics Market: Sales Value (in Million US$), 2015 & 2020
Figure 64: Europe: Genomics Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 65: Germany: Genomics Market: Sales Value (in Million US$), 2015 & 2020
Figure 66: Germany: Genomics Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 67: France: Genomics Market: Sales Value (in Million US$), 2015 & 2020
Figure 68: France: Genomics Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 69: United Kingdom: Genomics Market: Sales Value (in Million US$), 2015 & 2020
Figure 70: United Kingdom: Genomics Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 71: Italy: Genomics Market: Sales Value (in Million US$), 2015 & 2020
Figure 72: Italy: Genomics Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 73: Spain: Genomics Market: Sales Value (in Million US$), 2015 & 2020
Figure 74: Spain: Genomics Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 75: Russia: Genomics Market: Sales Value (in Million US$), 2015 & 2020
Figure 76: Russia: Genomics Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 77: Others: Genomics Market: Sales Value (in Million US$), 2015 & 2020
Figure 78: Others: Genomics Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 79: Latin America: Genomics Market: Sales Value (in Million US$), 2015 & 2020
Figure 80: Latin America: Genomics Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 81: Brazil: Genomics Market: Sales Value (in Million US$), 2015 & 2020
Figure 82: Brazil: Genomics Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 83: Mexico: Genomics Market: Sales Value (in Million US$), 2015 & 2020
Figure 84: Mexico: Genomics Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 85: Others: Genomics Market: Sales Value (in Million US$), 2015 & 2020
Figure 86: Others: Genomics Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 87: Middle East and Africa: Genomics Market: Sales Value (in Million US$), 2015 & 2020
Figure 88: Middle East and Africa: Genomics Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 89: Global: Genomics Industry: SWOT Analysis
Figure 90: Global: Genomics Industry: Value Chain Analysis
Figure 91: Global: Genomics Industry: Porter’s Five Forces Analysis
List of Tables
Table 1: Global: Genomics Market: Key Industry Highlights, 2020 and 2026
Table 2: Global: Genomics Market Forecast: Breakup by Component (in Million US$), 2021-2026
Table 3: Global: Genomics Market Forecast: Breakup by Application (in Million US$), 2021-2026
Table 4: Global: Genomics Market Forecast: Breakup by Technology (in Million US$), 2021-2026
Table 5: Global: Genomics Market Forecast: Breakup by End-User (in Million US$), 2021-2026
Table 6: Global: Genomics Market Forecast: Breakup by Region (in Million US$), 2021-2026
Table 7: Global: Genomics Market: Competitive Structure
Table 8: Global: Genomics Market: Key Players